Frazier Financial Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06K Buy
+22
New +$955 ﹤0.01% 645
2026
Q2
– Sell
-18
Closed -$487 – 802
2026
Q1
$487 Buy
+18
New +$605 ﹤0.01% 710

Other funds holding RIGL

Frazier Financial Advisors's RIGL Position: Q3 2026 in Review

Frazier Financial Advisors opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 22 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #645 among its holdings. This is a return to the name: Frazier Financial Advisors previously reported a position in RIGL as recently as Q1 2026.

Frazier Financial Advisors first reported a position in RIGL in Q1 2026 and has held it in 2 quarters since. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • Frazier Financial Advisors held 22 shares of Rigel Pharmaceuticals worth $1.06K as of Q3 2026.
  • Rigel Pharmaceuticals was a new Frazier Financial Advisors position in Q3 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q3 2026, its #645 holding.
  • Frazier Financial Advisors first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.